Litcius/Paper detail

Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study

Hiam Chemaitelly, Houssein H. Ayoub, Patrick Tang, Peter Coyle, Hadi M. Yassine, Asmaa A. Al Thani, Hebah A. Al-Khatib, Mohammad R. Hasan, Zaina Al Kanaani, Einas Al‐Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F. Abdul Rahim, Gheyath K. Nasrallah, Mohamed Ghaith Al‐Kuwari, Adeel A. Butt, Hamad Eid Al‐Romaihi, Mohamed H. Al‐Thani, Abdullatif Al‐Khal, Roberto Bertollini, Jeremy Samuel Faust, Laith J. Abu‐Raddad

2023The Lancet Infectious Diseases113 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCohortRetrospective cohort studyBooster doseVaccinationPopulationBooster (rocketry)Cohort studyProportional hazards modelOutbreakObservational studyPediatricsInternal medicineImmunologyImmune systemVirologyEnvironmental healthImmunizationAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Long-term COVID-19 booster effectiveness by infection history and clinical vulnerability and immune imprinting: a retrospective population-based cohort study | Litcius